Bisphosphonates are a class of drugs that slow bone loss by blocking the cells responsible for breaking down bone tissue. They are the most widely prescribed medications for osteoporosis and have been shown to reduce the risk of hip and spinal fractures by 40 to 70%. Doctors also prescribe them for several other bone-related conditions and certain cancers.
How Bisphosphonates Work
Your bones are constantly being remodeled. Specialized cells called osteoclasts dissolve old bone, while other cells called osteoblasts build new bone to replace it. In osteoporosis and other bone-weakening conditions, the breakdown side of this cycle outpaces the rebuilding side, leaving bones thinner and more fragile.
Bisphosphonates work by attaching to the mineral surface of bone and getting absorbed by osteoclasts when those cells come to break the bone down. Once inside the cell, the drug disrupts its ability to function and eventually triggers cell death. With fewer active osteoclasts, bone breakdown slows dramatically, and the balance tips back toward preservation.
There are two subcategories. Older, non-nitrogen-containing bisphosphonates get incorporated into the cell’s energy molecules and poison the osteoclast from the inside by interfering with energy-dependent processes. Newer, nitrogen-containing bisphosphonates (which include most of the commonly prescribed options today) work differently: they block an enzyme in a metabolic pathway the osteoclast needs to maintain its structure and stay alive. Both types achieve the same result, but through different biochemical routes.
Conditions Bisphosphonates Treat
Osteoporosis is the most common reason for a bisphosphonate prescription, but these drugs have a broader range of approved uses:
- Osteoporosis in postmenopausal women, in men, and in people who develop it from long-term corticosteroid use
- Paget’s disease of the bone, a condition where bone remodeling becomes chaotic, producing weak and misshapen bones
- Cancer-related high blood calcium (hypercalcemia of malignancy), which happens when tumors cause excessive bone breakdown and flood the bloodstream with calcium
- Cancer that has spread to the bones, including multiple myeloma, where bisphosphonates help reduce skeletal damage and pain
Off-label, they are sometimes used for osteogenesis imperfecta (a genetic condition causing brittle bones) and to protect bone density in organ transplant candidates.
Oral vs. Intravenous Forms
Bisphosphonates come in two delivery formats. Oral versions, such as alendronate and risedronate, are taken as tablets, typically once a week or once a month depending on the specific drug. Intravenous versions, such as zoledronic acid and pamidronate, are given as infusions at a clinic, sometimes as infrequently as once a year for osteoporosis or every few months for cancer-related conditions.
IV bisphosphonates bypass the digestive system entirely, which makes them a good option for people who can’t tolerate the oral forms or have trouble following the strict dosing instructions that oral versions require.
How to Take Oral Bisphosphonates
Oral bisphosphonates are notoriously picky about how they’re taken. The drugs absorb poorly, and food, drinks, or supplements in the stomach can block absorption almost entirely. To get the full benefit, you need to follow a specific routine.
Take the tablet first thing in the morning on a completely empty stomach. Swallow it whole with a full glass (6 to 8 ounces) of plain water only. Do not use mineral water, coffee, juice, or anything else. After swallowing, stay sitting or standing upright for at least 60 minutes, and do not eat, drink anything other than plain water, or take any other medications (including calcium or vitamins) during that window. Lying down too soon can cause the tablet to irritate or even ulcerate the esophagus.
Common Side Effects
The most frequent complaints with oral bisphosphonates involve the upper digestive tract: heartburn, nausea, stomach pain, and irritation of the esophagus. These problems are closely tied to how the pill is taken, which is why the dosing instructions are so specific. Taking the tablet correctly with a full glass of water and remaining upright significantly reduces the risk.
IV bisphosphonates tend to cause a different set of short-term effects. Many people experience flu-like symptoms after their first infusion: fever, muscle aches, headaches, and fatigue. These typically start within a day or two and resolve on their own within 72 hours. The reaction is usually milder or absent with subsequent infusions.
Rare but Serious Risks
Two rare complications get the most attention with long-term use, and both are worth understanding in context.
The first is osteonecrosis of the jaw, where a section of jawbone loses its blood supply and begins to deteriorate. In people taking bisphosphonates for osteoporosis, this affects roughly 1 in 10,000 to 1 in 100,000 patients. The risk rises modestly with duration of use, reaching about 0.21% after four or more years compared to a baseline of about 0.1%. It is far more common in cancer patients receiving much higher doses intravenously, especially those who have had dental surgery.
The second is atypical femur fractures, unusual breaks in the thighbone that occur with minimal trauma. These affect about 1.8 per 100,000 people per year after two years of bisphosphonate use, but the rate climbs substantially with very long treatment: up to 113 per 100,000 per year after eight to ten years. This escalating risk with duration is one of the main reasons doctors now recommend treatment breaks for many patients.
How Long Treatment Lasts
Bisphosphonates are not meant to be taken indefinitely. Because the drugs bind tightly to bone mineral and continue releasing slowly even after you stop taking them, their protective effects linger for months or years after discontinuation. This creates an opportunity for a “drug holiday,” a planned break from treatment that reduces the risk of rare complications while still maintaining much of the bone protection.
How long you take bisphosphonates before a holiday depends on your fracture risk. People at mild risk typically take them for three to five years and then stop. Those at moderate risk may continue for five to ten years before pausing for three to five years. People at the highest risk, such as those with previous fractures, very low bone density, or long-term corticosteroid use, may be treated for up to ten years before taking a shorter holiday of one to two years, sometimes switching to a different type of bone-protective medication during the break.
During a drug holiday, your doctor will monitor your bone density periodically. How soon you need to be rechecked depends partly on which bisphosphonate you were taking, because different drugs cling to bone for different lengths of time. Risedronate’s effects fade faster, so reassessment is typically recommended after about one year. Alendronate warrants a check at one to two years. Zoledronic acid, which binds most tightly to bone, can often be reassessed at two to three years after stopping.
Who Should Not Take Bisphosphonates
Bisphosphonates are cleared through the kidneys, and all of them carry warnings or contraindications for people with severe kidney impairment, generally defined as kidney filtration rates below 30 to 35 mL per minute. People with active esophageal problems, such as strictures or difficulty swallowing, are typically not given the oral forms because of the risk of esophageal damage. Low blood calcium levels also need to be corrected before starting treatment, since bisphosphonates can lower calcium further by slowing its release from bone.